FDA approves another abortion pill, sparks conservative backlash

The FDA's recent approval of another version of the abortion pill mifepristone marks a significant step in reproductive health access, following its initial approval in 2000. This decision is crucial as it expands options for individuals seeking abortion services, especially amidst ongoing debates and conservative backlash against reproductive rights. The approval reflects a growing recognition of the importance of accessible healthcare choices.